Efficacy of 91.2% with two doses of Soberana 02 and one of Soberana Plus
The combination of two doses of the candidate vaccine Soberana 02 and one of Soberana Plus, administered in a 0-28-56 day regimen, was found to have an efficacy of 91.2 percent, in preventing symptomatic cases of COVID-19, reported Dr. Vicente Vérez Bencomo, director of the Finlay Vaccine Institute (IFV), at Thursday's meeting of the Cuban government’s COVID-19 prevention and control task force.